European markets head for higher open as traders focus on data, earnings

European markets head for higher open as traders focus on data, earnings


Thyssenkrupp books $1 billion impairment on struggling steel unit

A general view of the gate of the Thyssenkrupp industrial area in Duisburg, Germany, on August 29, 2024. (Photo by Ying Tang/NurPhoto via Getty Images).

Nurphoto | Nurphoto | Getty Images

Germany’s Thyssenkrupp on Tuesday reported a 1-billion-euro ($1.06 billion) impairment on its struggling steel division as the industrial powerhouse flagged “gloomy volume” expectations and structural challenges in the sector.

The firm said its net loss of 1.5 billion euros in the fiscal year ending Sept. 30 — after deducting minority interest — was mainly due to asset impairments totaling around 1.2 billion euros, of which 1 billion euros were undertaken by its Steel Europe division.

Read the full story here.

— April Roach

European markets: Here are the opening calls

European markets are expected to open higher Tuesday.

The U.K.’s FTSE 100 index is expected to open 39 points higher at 8,144, Germany’s DAX up 53 points at 19,227, France’s CAC up 24 points at 7,298 and Italy’s FTSE MIB up 115 points at 34,002, according to data from IG.

Earnings come from Imperial Brands and Thyssenkrupp and finalized euro zone inflation data for October is due.

— Holly Ellyatt

CNBC Pro: ‘Top quality asset’: Strategist names his top stock to buy in India right now

Indian markets have been under pressure in recent weeks, but strategist Matt Orton remains bullish on the country, revealing “one of his favorite” stocks right now.

“India has been my most overweight country and that still remains the fact outside of the U.S.,” the chief market strategist at asset management firm Raymond James Investment Management said, naming a stock that is one of his favorites.

CNBC Pro subscribers can read more here.

— Amala Balakrishner

Fed can be ‘patient’ due to economic strength, CIO says

One reason the postelection rally for stocks appears to have stalled may be that investors are growing less confident in the rate cut path of the Federal Reserve.

According to the CME FedWatch Tool, trading in the fed funds futures market currently implies a 62.1% likelihood of a rate cut in December. That is down from 65.3% a week ago, and 76.8% a month ago.

Jim Baird, chief investment officer at Plante Moran Financial Advisors, said recent signs of continued strength for the economy could lead to the Fed slowing its pace of cuts.

“It is going to call into question how much more they need to cut, and how quickly. I think that’s what they’ve really been hinting at — that they’re going to be patient, they’re going to be data dependent, and that could mean a slower pace of rate cuts than either their forecasts have suggested or the market was expecting,” Baird said.

Baird added that the effect of the election, such as the potential for higher tariffs under President-elect Donald Trump, “exacerbate” those questions about how much the Fed will cut.

— Jesse Pound

CNBC Pro: ‘Go for gold’ says Goldman Sachs, but other Wall Street banks aren’t so sure

Three Wall Street banks have taken differing views on gold’s trajectory in 2025, reflecting the complex economic outlook.

Goldman Sachs expects the price of the yellow metal to reach $3,000 per ounce by December 2025, saying “Go For Gold” in a note from Nov. 17.

Others, however, including JPMorgan and UBS, have taken a different view.

CNBC Pro subscribers can read more here.

Stock Chart IconStock chart icon

hide content

Gold



Source

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More
CNBC Daily Open: Hawkish hold from BOJ sets central bank stage
World

CNBC Daily Open: Hawkish hold from BOJ sets central bank stage

The Bank of Japan headquarters in Tokyo on May 30, 2024. Kazuhiro Nogi | Afp | Getty Images Hello, this is Katie Foley writing to you from London. I spend my mornings leading the London TV teams as we prepare to take Europe Early Edition and Squawk Box Europe to air. Over the last two […]

Read More